Diabetic kidney disease (DKD) has been the leading cause of chronic kidney disease for
over 20 years. Yet, over these two decades, the clinical approach to this condition has not …

Diabetic kidney disease (DKD) is one of the most common causes of end-stage renal
disease worldwide. The treatment of DKD is strongly associated with clinical outcomes in …

Adiponectin (APN) is an adipokine concerned in the regulation of glucose metabolism,
insulin sensitivity and fatty acid oxidation. APN plays a critical role in viral infections by …

Metabolic syndrome (MetS), ie a cluster of physiological and biochemical abnormalities can
lead to diabetic nephropathy (DN). Insulin resistance, impaired fasting glucose are the main …

Bergenin (BG) is a polyphenolic substance which has therapeutic potential in the treatment
of diabetic nephropathy (DN), a common complication of type II diabetes. However, the …

Hyperglycemia, characterized by high blood glucose levels resulting from pancreatic beta
cell dysfunction or impaired insulin signaling, is a contributing factor in the development of …

Backgrounds: Inadequate sleep duration is associated with a higher risk of type 2 diabetes
and the relationship is nonlinear. We aim to assess the curve relationship between night …

Diabetes mellitus is the leading cause of chronic kidney disease, and about 30–40% of
patients with diabetes will develop kidney disease. Incretin hormones have received …

Diabetic kidney disease (DKD) is a major microvascular complication of diabetes mellitus
(DM) that poses a serious risk as it can lead to end-stage renal disease (ESRD). DKD is …

BACKGROUND NLRP3-mediated pyroptosis is recognized as an essential modulator of
renal disease pathology. Long noncoding RNAs (lncRNAs) are active participators of …